Skip to content

Dolby Laboratories, Inc. DLB Business Segments — Stock-based compensation expense

Similar metrics at other companies

Twist Bioscience Corporation logo
TWSTReportable Segment — Stock-based compensation expense
$18.94M-6.8%
Hinge Health, Inc. logo
HNGEReportable Segment — Stock-based compensation expense
$11.69M+166,929%
Enphase Energy logo
ENPHReportable Segment — Stock-based compensation expense
$48.99M-11.9%
WillScot Holdings Corporation logo
WSCReportable Segment — Stock compensation expense
$7.11M-14.8%
Synaptics logo
SYNAReportable Segment — Stock-Based Comp
$300K0.0%
Mirum Pharmaceuticals, Inc. logo
MIRMReportable Segment — Stock-Based Comp
$57.13M+269%

Other financials

Income statement

See full
Revenue$395.6M+7.1%
Gross profit$350.9M+5.1%
Operating income$112.9M+4.8%
Net income$94.9M+3.4%
EPS (diluted)$0.99+5.3%

Balance sheet

See full
Cash & equivalents$673.8M-10.2%
Total debt$49.7M+22.9%
Total equity$2.6B+1.7%
Total assets$3.2B+0.6%

Cash flow

See full
Operating cash flow$92.5M-47.1%
CapEx$9.1M+31.4%
Free cash flow$83.4M-50.3%

Valuation

See full
Market cap$4.95B-25.9%

Profitability

See full
Gross margin87.4%-1.5pp
Operating margin18.5%-2.0pp
Net margin17.9%-1.6pp
FCF margin22.1%-7.5pp

Returns & leverage

See full
Return on equity9.4%-0.9pp
Debt / equity0.0×
Current ratio-0.1×

Where this comes from

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue.

The official record: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dolby Laboratories, Inc.'s business segments — stock-based compensation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dolby Laboratories, Inc.'s business segments — stock-based compensation expense?
Dolby Laboratories, Inc. (DLB) reported business segments — stock-based compensation expense of $30.71M in Q1 2026.
How has Dolby Laboratories, Inc.'s business segments — stock-based compensation expense changed year-over-year?
Dolby Laboratories, Inc.'s business segments — stock-based compensation expense increased by 0.1% year-over-year, from $30.66M to $30.71M.
What does business segments — stock-based compensation expense mean?
Measures the non-cash expense recognized for equity-based awards granted to employees within the segment. It is a critical component for understanding true labor costs and the dilution impact on existing shareholders.